Edwards Lifesciences is a global leader in structural heart innovation, developing, manufacturing, and marketing medical devices for cardiovascular care. The company's core expertise lies in artificial heart valves and hemodynamic monitoring solutions. Its technical domains include cardiovascular medical devices, transcatheter aortic heart valve replacement (TAVR), and hemodynamic monitoring.
Among its key products is the Transcatheter Heart Valve (THV), a device designed to replace aortic heart valves without the need for open heart surgery. This technology represents a significant focus of the company's work in minimally invasive cardiac procedures.
The company has been in operation for over 65 years and maintains a global presence, with products available in more than 100 countries. It operates within the healthcare, medical devices, and cardiovascular care industry verticals.
